Last reviewed · How we verify

corticoid (altim® 1.5 ml)

Nantes University Hospital · FDA-approved active Small molecule

Corticosteroids suppress immune and inflammatory responses by binding to glucocorticoid receptors and inhibiting pro-inflammatory cytokine production.

Corticosteroids suppress immune and inflammatory responses by binding to glucocorticoid receptors and inhibiting pro-inflammatory cytokine production. Used for Inflammatory and allergic conditions (specific indication for Altim® formulation not definitively established in available data).

At a glance

Generic namecorticoid (altim® 1.5 ml)
SponsorNantes University Hospital
Drug classCorticosteroid
TargetGlucocorticoid receptor
ModalitySmall molecule
Therapeutic areaImmunology / Inflammation
PhaseFDA-approved

Mechanism of action

Corticosteroids like those in Altim® work by entering cells and binding to intracellular glucocorticoid receptors, which then translocate to the nucleus and modulate gene expression. This leads to decreased production of inflammatory mediators (cytokines, chemokines, adhesion molecules) and suppression of immune cell activation and proliferation. The result is broad anti-inflammatory and immunosuppressive effects useful across multiple therapeutic contexts.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: